COVID-19 and mRNA Vaccines-First Large Test for a New Approach.

  title={COVID-19 and mRNA Vaccines-First Large Test for a New Approach.},
  author={Jennifer Abbas{\'i}},
As some communities in the United States begin to convene youth camps, CDC offers the following suggestions for ways in which camp administrators can help protect campers, staff, and communities, and prevent the spread of COVID-19 Camp administrators can determine, in collaboration with state and local health officials, whether and how to implement these considerations, making adjustments to meet the unique needs and circumstances of the local community Implementation should be guided by what… 

COVID-19 Management in Pediatrics

Addressing COVID-19 vaccine hesitancy - healthcare workers and trainees must be equipped for discussions about vaccines

A brief review outlines some arguments for why a COVID-19 vaccine is necessary and clarifies some features of the current top vaccine candidates.

Are We Ready for the Arrival of the New COVID-19 Vaccinations? Great Promises and Unknown Challenges Still to Come

While the SARS-CoV-2 pandemic continues to strike and collect its death toll throughout the globe, as of 31 January 2021, the vaccine candidates worldwide were 292, of which 70 were in clinical

Racing to immunity: Journey to a COVID‐19 vaccine and lessons for the future

A list of all COVID‐19 vaccines undergoing pre‐clinical and clinical testing using the WHO and database is compiled to facilitate a more thorough understanding of the extensive CO VID‐19 clinical testing vaccine landscape as it unfolds, and better highlight some of the complexities and challenges being faced by the joint effort of the scientific community in finding a prophylactic against COvid‐19.

SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?

The Trilogy of SARS-CoV-2 in Pediatrics (Part 1): Acute COVID-19 in Special Populations.

  • S. ParsonsV. Tran
  • Medicine
    The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
  • 2021
The pharmacologic treatment and prevention therapies used in pediatric patients to date, including emergency use authorizations, as well as rationales for pharmacotherapies not routinely used to treat acute COVID-19 infection are evaluated.

Monkeypox: Emerging virus of concern; antivirals and vaccines therapeutic options

mRNA vaccines for COVID-19 and diverse diseases

COVID-19 Vaccine Hesitancy and Determinants of Acceptance among Healthcare Workers, Academics and Tertiary Students in Nigeria

In the multivariable model, location of respondents/geopolitical zones, level of education, testing for COVID-19, occupation/job description and religion were significantly associated with VH, underscoring the need for targeted awareness creation to increase CO VID-19 vaccination coverage in Nigeria and elsewhere.

The impact of health policies and vaccine rollout on the COVID-19 pandemic waves in Italy